Supplier-designated peptide; identity pending

TB-500

TB-500 is retained as the supplier name. Published analytical work uses an acetylated thymosin-beta-4 fragment; this does not establish the sequence or equivalence of the supplied material.

BLOPEP vial — representative image — Representative image

Representative image

Quantity per vial

Select variantCompare prices and choose a variant to set the quantity and add it to your quote.

2 mgper vial$79.00/ box5 mgper vial$129.00/ box10 mgper vial$239.00/ box

Subtotal excludes freight and taxes. Availability and final terms are confirmed in the quote. Commercial and shipping terms

Mechanism and findings →

Mechanism and findings

Mechanism of action

TB-500 — supplier-designated peptide; identity pending. The literature identity must be matched to the documented chemical form and composition of the supplied material.

Sources and studies 1

Peptide Monographs

Doping control analysis of TB-500, a synthetic version of an active region of thymosin β₄, in equine urine and plasma by liquid chromatography-mass spectrometry.
Ho EN, Kwok WH, Lau MY, Wong AS, Wan TS, Lam KK, Schiff PJ, Stewart BD · 2012 · Journal of chromatography. A
DOI: 10.1016/j.chroma.2012.09.043

Specifications and packaging

Nominal variant content; analytical results belong to the documented batch.

Material type: Peptide

Quality and analyses

Review specifications, analytical results and documentation for published batches.

Purity: >99%
Type: Declared specification

Published batches

Batch results have not yet been published on this page.

Storage

Consult the specific conditions in the supplied material documentation.

Delivery and commercial terms

Destination

Freight, timing and import terms will be confirmed in the quote for the selected destination.